Oregon

The Board of Pharmacy is proposing to adopt the following rules. A hearing will be held on November 22 at 9:30 a.m. PT. Written comments may be filed before 4:30 p.m. PT on November 22 via email to pharmacy.rulemaking@bop.oregon.gov. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-11-18T11:10:44-05:00November 18, 2022|Oregon|

Texas

Gov. Greg Abbott (R) directed the Texas Education Agency (TEA) and the school superintendents that the COVID-19 vaccine cannot be mandated as part of school entry requirements. Instead, Texas law overrides a recent recommendation from the Centers for Disease Control (CDC) that added the vaccine to immunization schedules for adults and school-aged children. In letters to TEA Commissioner Mike Morath and school superintendents statewide, the Governor explains that his Executive Order No. GA-39, issued on August 25, 2021, allows Texas parents to opt-out of the COVID-19 vaccine for their children and further empowers parents to be the primary decision-makers in their children’s healthcare. Also, the Texas Legislature has enabled parents to opt out of vaccinating their children for health reasons and reasons of conscience through several statutes, including Texas Education Code § 38.01(c)(1), Texas Health & Safety Code §§ 161.004(d), 161.0041 and Texas Human Resources Code § 42.043(d). 

Also in Texas, the Health, and Human Services Commission (HHSC) Vendor Drug Program (VDP) Medicaid is soliciting feedback on its proposed policies related to the transition of the formulary, preferred drug list and prior authorization requirements to managed care organizations, in accordance with state law. The survey must be completed by 5:00 PM CT on December 4, 2022. 

Also in Texas, at the Board of Pharmacy early this month, the Board adopted and proposed several rules. 

Finally in Texas, November 14 was the first day of bill filing for the 2023 legislative session that convenes on January 10, 2023. Shortly after Noon, legislators had filed more than 800 bills. Thousands of pieces of legislation are filed each biennial session, but most never make it into law.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-11-18T11:09:19-05:00November 18, 2022|Texas|

Alabama

Pharmacist registrations expire December 31, 2022. The Board of Pharmacy is accepting pharmacist license renewals ONLINE ONLY at www.albop.com. The renewal fee is $100 plus $100 for a controlled substance permit. If you are changing your name, send proof of legal name change BEFORE YOU REGISTER ONLINE. If you fail to renew your license by December 31, 2022, but you continue to work as a pharmacist in any way, you will be subject to late fees and discipline. For more information, please contact the Board of Pharmacy directly at 205-981-2280.  

Also in Alabama, please see these updated ALERTS for billing for Stand-alone COVID-19 Vaccine Counseling for Recipients Under Age 21 and billing for Stand-alone Vaccine Counseling to Recipients Under Age 21.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-11-04T11:36:09-04:00November 4, 2022|Alabama|

Alaska

The Board of Pharmacy’s statutes and regulations booklet has been updated to reflect sections 1 – 10 of HB 145, the new pharmacist and pharmacy technicians expanded practice law passed this year. The October 2022 booklet reflects these changes to AS 08.80: 

  • Permits pharmacists to engage in independent monitoring of drug therapy; 
  • Clarifies pharmacists can independently prescribe and administer vaccines, related emergency medications, and opioid overdose drugs; 
  • Permits pharmacy technicians to administer vaccines or related emergency medications, if approved by the board; 
  • Requires interns and technicians to disclose prescription drug prices;  
  • Permits pharmacists to provide patient care services outside of a collaborative practice agreement with a physician for general health and wellness, disease prevention and certain conditions, including conditions that involve CLIA-waived tests; 
  • Removes dosage form from equivalent drug product and 
  • Updates the definition of “practice of pharmacy” 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-11-04T11:35:40-04:00November 4, 2022|Alaska|

California

The Board of Pharmacy has announced an additional meeting of the Standard of Care Ad Hoc Committee schedule for November 16 and posted an agenda for the meeting. 

Also in California, the Department of Health Care Services posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal. Please note the Medi-Cal recoupment announcement in “Recommencement of Pharmacy Retroactive Claims Adjustments” document; these recoupments are set to begin in January 2023.  

Finally in California, Medi-Cal posted the following: 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-11-04T11:34:19-04:00November 4, 2022|California|

Florida

As of September 29, 2022, the Federal Emergency Management Agency (FEMA) issued a major disaster declaration for the following Florida counties affected by Hurricane Ian (DR-4673): Brevard, Charlotte, Collier, DeSoto, Flagler, Glades, Hardee, Hendry, Highlands, Hillsborough, Lake, Lee, Manatee, Monroe, Okeechobee, Orange, Osceola, Palm Beach, Pasco, Pinellas, Polk, Putnam, Sarasota, Seminole, St. Johns, and Volusia.

The Agency for Health Care Administration (Agency) announced it will ensure reimbursement for all services provided in good faith to eligible Florida Medicaid recipients in FEMA designated counties during the Disaster Grace Period. The Agency is defining the Disaster Grace Period for Hurricane Ian as September 29, 2022 through November 30, 2022.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-11-04T11:33:43-04:00November 4, 2022|Florida|

Illinois

This notice implements the section of Public Act 102-0103 that allows pharmacists to bill and be reimbursed for patient care services for hormonal contraceptives. This new policy is effective with dates of service on and after August 1, 2022, and applies to the Medicaid fee-for-service (FFS) program and the HealthChoice Illinois (HCI) managed care organization (MCO) plans.  

Also in Illinois, this notice provides an update on coverage of the new COVID-19 bivalent boosters. The update applies to claims for customers covered under traditional Medicaid fee-for-service (FFS) and the HealthChoice Illinois (HCI) managed care organization (MCO) plans.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-11-04T11:33:06-04:00November 4, 2022|Illinois|
Go to Top